Pharmacy

Alpha Index Z

Home » Alpha Index » Alpha Index Z

List of Drugs:

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Z  #

Products Z:

ZAART H Hyzaar

Zanaflex (Tizanidine)

Zantac Generic Ranitidine

Zantac (Ranitidine)

Zarontin Generic Ethosuximide

Zarontin Syrup Generic Ethosuximide

Zebeta (Bisoprolol)

Zeffix Generic Imaivudine

Zelnorm (Tegaserod)

Zerit (Stavudine)

Zero Nicotine

Zestoretic (Lisinopril + Hydrochlorothiazide)

Zestril (Lisinopril)

Zestril Prinivil

Zetia (Ezetimibe)

ZIDOVIR 300 AZT

ZIDOVIR AZT

Ziprax Suprax

Zipsydon Geodon

Zithromax Generic Azithromycin

Zithromax (Azithromycin)

Zitrotek Zithromax

ZOBID D Voltaren

Zocon Diflucan

Zocor

Zocor Forte Lipex

Zocor (Simcard)

ZOFLUT Generic Fluticasone

Zofran Generic Ondansetron

Zofran (Ondansetron)

Zoladex Generic Goserelin

Zoloft Lustral

Zomig Generic Zolmitriptan

ZONISEP Zonegran

Zoton Prevacid

Zovirax Generic Aciclovir

Zovirax (Acyclovir)

Zovirax Ophtalmic Pomade Generic Aciclovir

Zovirax Pump Pack Cream for Herpes Generic Aciclovir

Zurig Uloric

Zyban (Bupropion)

Zyban Wellbutrin

Zycolchin Colchicum

Zyloprim (Allopurinol)

ZYLORIC Lopurin

Zymar Eye Drops Generic Gatifloxacin

Zynicor Ikorel

ZYRTEC Generic Cetirizine

Zyrtec (Cetirizine)

Previous 

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.